Skip to main content
SpringerLink
Log in

Safety updates from New Zealand’s Medsafe

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Medsafe.Dabigatran etexilate (Pradaxa): Summary of reports to CARM. Prescriber Update 32: 29-30, No. 4, Dec 2011. Available from: URL: http://www.medsafe.govt.nz

  2. Medsafe.M2 update: Quetiapine and cardiomyopathy - an emerging safety signal. Prescriber Update 32: 31, No. 4, Dec 2011. Available from: URL: http://www.medsafe.govt.nz

  3. Medsafe.Alert: Safety of Ayurvedic products - reports of lead poisoning. Prescriber Update 32: 32, No. 4, Dec 2011. Available from: URL: http://www.medsafe.govt.nz

  4. Medsafe.Modafinil safety review - a wake up call. Prescriber Update 32: 33, No. 4, Dec 2011. Available from: URL: http://www.medsafe.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Safety updates from New Zealand’s Medsafe. React. Wkly. 1383, 3 (2012). https://doi.org/10.2165/00128415-201213830-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00007

Keywords

Search

Navigation